Leaving search fields blank may affect search results
Your search includes information provided by Pfizer Medical Information, content of which is intended for health care professionals only. These results may contain information regarding indications and/or uses of Pfizer products that are not approved by the U.S. Food and Drug Administration. Would you like to continue and view these search results?
Per Pfizer policy, you must be a validated health care professional in order to submit your medical inquiry to Pfizer Medical Information.
Please click here to enter your health care professional credentials or sign-in.
New User?
Returning User?
Benefits of registering
Indication CAMPTOSAR Injection is indicated as a component of first-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. CAMPTOSAR is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
Update: A Treatment Continuum in mCRC: Strategic Approach to Extend Survival This slide kit presents an evidence-based view of current treatment strategies for advanced colorectal cancer.
Full Prescribing Information
Back to Top